These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 143343)

  • 1. In vitro inhibition of human leukemic cells (CCRF-CEM) by agarose-immobilized neocarzinostatin.
    Lazarus H; Raso V; Samy TS
    Cancer Res; 1977 Oct; 37(10):3731-6. PubMed ID: 143343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antitumor activity of neocarzinostatin (NCS)-tumor antibody conjugate against a transplantable human leukemia cell line (BALL-1).
    Kimura I; Tsubota T; Ohnoshi T; Sato Y; Okazaki M; Manabe Y; Abe S
    Jpn J Clin Oncol; 1983 Jun; 13(2):425-33. PubMed ID: 6224954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth.
    Müller WE; Maidhof A; Arendes J; Geurtsen W; Zahn RK; Schmidseder R
    Cancer Res; 1979 Sep; 39(9):3768-73. PubMed ID: 89904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effect of neocarzinostatin on human lymphoid cells.
    Maeda H; Matsumoto M
    Tohoku J Exp Med; 1979 Aug; 128(4):313-23. PubMed ID: 225845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a glucocorticoid-sensitive human lymphoid cell line.
    Norman MR; Thompson EB
    Cancer Res; 1977 Oct; 37(10):3785-91. PubMed ID: 269011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding to and internalization by cultured cells of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrene-maleic acid copolymer.
    Oda T; Maeda H
    Cancer Res; 1987 Jun; 47(12):3206-11. PubMed ID: 2953411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular fate of protein antibiotic neocarzinostatin in culture of a lymphoid cell line from Burkitt's lymphoma.
    Maeda H; Aikawa S; Yamashita A
    Cancer Res; 1975 Mar; 35(3):554-9. PubMed ID: 1116122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Targeting chemotherapy with transferrin-neocarzinostatin conjugate].
    Kohgo Y; Kato J; Sasaki K; Kondo H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1072-6. PubMed ID: 2968779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
    Suzuki F; Okuno Y; Maeda Y; Maeda H
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3305-12. PubMed ID: 2961306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neocarzinostatin: effect of modification of side chain amino and carboxyl groups on chemical and biological properties.
    Samy TS
    Biochemistry; 1977 Dec; 16(25):5573-8. PubMed ID: 144523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
    Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
    Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of thymidine-resistant cells from a thymidine-sensitive acute lymphoblastic leukemia cell line.
    Zielke HR
    Cancer Res; 1979 Sep; 39(9):3373-6. PubMed ID: 289439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives.
    Kanter PM; Schwartz HS
    Cancer Res; 1979 Sep; 39(9):3661-72. PubMed ID: 476691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of cytotoxicity of zinostatin under acidic conditions in vitro and in vivo.
    Kuroiwa T; Taniguchi S; Aoki K; Hasuda K; Baba T
    Cancer Treat Rep; 1987 Mar; 71(3):247-51. PubMed ID: 2949830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH.
    Oda T; Sato F; Maeda H
    J Natl Cancer Inst; 1987 Dec; 79(6):1205-11. PubMed ID: 2961908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
    Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
    Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the cytotoxic effects of the high- and low-molecular-weight anticancer agents on multidrug-resistant Chinese hamster ovary cells in vitro.
    Miyamoto Y; Oda T; Maeda H
    Cancer Res; 1990 Mar; 50(5):1571-5. PubMed ID: 2137371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT; Cirtain MC; Look AT; Ashmun RA
    Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
    Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
    Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.